top of page

Orforglipron Hemicalcium Hydrate

Orforglipron Hemicalcium Hydrate | CAS 3008544-96-2 API Manufacturer & Supplier in China

Looking for Orforglipron Hemicalcium Hydrate API CAS 3008544-96-2?
Conscientia Industrial is a leading API manufacturer & supplier of high-purity Orforglipron Hemicalcium Hydrate in China. Offering ≥99.0% purity, stable industrial supply, and fast global shipping. Request Price, COA, and MSDS from Conscientia Industrial now.

Product Overview

Orforglipron Hemicalcium Hydrate (CAS 3008544-96-2), is a cutting-edge, non-peptide oral glucagon-like peptide-1 (GLP-1) receptor agonist. Within the Pharmaceutical APIs and advanced metabolic research sectors, it represents a significant technological leap as a small-molecule alternative to traditional injectable peptide therapies. As a leading API manufacturer of Orforglipron Hemicalcium Hydrate CAS 3008544-96-2 based in China, Conscientia Industrial utilizes high-precision asymmetric synthesis and sophisticated calcium salt-formation protocols to ensure the highest structural integrity and optimal bioavailability of this molecule. Our product serves as a vital technical component for laboratory research and the development of next-generation oral metabolic formulations, maintaining a strict purity profile to meet global technical requirements for high-potency research materials.

Conscientia Industrial also manufactures Orforglipron CAS 2212020-52-3 and keeps it in stock for fast global shipping.


Technical Specifications

  • Product Name: Orforglipron Hemicalcium Hydrate

  • CAS Number: 3008544-96-2

  • Category: Pharmaceutical APIs

  • Quality Standard: In-House

  • Molecular Formula: C48H48F2N10O5.1/2Ca.H2O

  • Molecular Weight: 921.02

  • Identification: HPLC; IR

  • Appearance: White to off-white powder

  • Solubility: Soluble in Ethanol and Methanol

  • Purity (HPLC): ≥99.0%

  • Single Impurity: ≤0.5%

  • Total Impurities: ≤1.0%

  • Water Content: 4.0% - 6.5%

  • Calcium Content: 1.8% - 2.4%

  • Heavy Metals: ≤10ppm

  • Brand: Conscientia Industrial

  • Country of Origin: China

  • Availability: In Stock

  • Pricing: Competitive price based on order quantity

  • Currency: USD

  • Molecular Structure:





Why Partner with Conscientia Industrial

  • Non-Peptide GLP-1 Expertise: Specialized in the synthesis and stabilization of next-generation small molecule GLP-1 receptor agonists.

  • Technical Quality Control: Our manufacturing process follows rigorous analytical protocols to ensure high-grade batch-to-batch consistency for Orforglipron Hemicalcium Hydrate CAS 3008544-96-2.

  • Advanced Analytical Verification: Every batch is validated through HPLC, NMR, and ICP-MS (for calcium content) to confirm chemical identity and minimize process-related impurities.

  • Full Technical Documentation: We provide comprehensive support, including Certificate of Analysis (COA), MSDS, and Method of Analysis (MOA) of Orforglipron Hemicalcium Hydrate for technical evaluation.

  • Scalable Production Capacity: Our China facility is equipped to support projects ranging from small-scale laboratory trials to specialized industrial supply volumes.

  • Direct Source Advantage: As a primary manufacturer, we provide Orforglipron Hemicalcium Hydrate CAS 3008544-96-2 with efficient lead times and direct factory technical support.


Packaging & Storage

  • Standard Packaging: 1g, 10g, 100g, 1kg, 10kg bulk vacuum-sealed aluminum foil bags for large orders.

  • Storage Conditions: Store at room temperature. Maintain in a tightly sealed container, protected from light and moisture to ensure long-term stability.

  • Shelf Life: 24 months.

  • Safety Handling: This is a professional-grade API intended for industrial pharmaceutical production and laboratory research use only.


Our logistics team ensures secure distribution of Orforglipron Hemicalcium Hydrate CAS 3008544-96-2 via global courier, air freight, and sea freight.


Request a Quote & COA for Orforglipron Hemicalcium Hydrate CAS 3008544-96-2 Today.

Expert Review
Rating: 5/5
★★★★★ Daniel Hughes (QA Director)
The API demonstrates high purity and consistent batch-to-batch quality. It performs well and meets required specifications for our pharmaceutical manufacturing.

bottom of page